Navigation Links
Israeli Innovation Shown to Demonstrate Reduction in Headaches and Neck Pain

TEL AVIV, Israel, November 26, 2012 /PRNewswire/ --

Israel-based medical device company  Headway medical  reports the successful completion of a series of clinical trials of Occiflex, its innovative therapeutic table designed to reduce chronic neck pain and headaches. The device will be available, starting in 2013, to physiotherapy clinics and rehabilitation centers throughout the world.

A revolutionary new device based on the principles of physiotherapy, Occiflex supports slow, repeated, and precise treatment for patients with muscle-dysfunction-related chronic pain. The Occiflex table mechanism allows physiotherapists to devise a manual mobilization file that is tailored to the needs of each patient, and, since it does not depend on the therapist's physical abilities, it can continue therapy for much longer than is standard and possible today. Plus, since each patient's therapy protocol is saved in a database, treatment can be reproduced precisely each time. The patient's file can be modified at any time, as conditions changes. The Occiflex treatment table improves the condition of the cervical joints, muscle, ligaments, and central nervous system control over the neck and head.

The Clinical Journal of Pain recently published a scientific article that describes the clinical trial conducted by Headway in the physiotherapy department of the Bnei Zion Medical Center in Haifa, Israel. The trial tested the advanced prototype developed by the company. Results indeed demonstrated a reduction of chronic neck pain in the patients and increased mobility.

According to Tamir Levital, CEO of Headway, "Occiflex will make the work of 50,000 physiotherapy and pain centers around the world more efficient and provide relief for the hundreds of millions who suffer from chronic neck pain and headaches. It will also save physiotherapists time and energy, and permit them to treat a number of patients simultaneously. The results of our trials show that Occiflex permits more precise, effective, repeated, and longer treatment than is possible today. We are very happy with the results of the trial and are getting ready to market Occiflex starting in 2013."

Headway, which got its start in the Misgav Venture Accelerator (owned by the Trendlines Group), was founded in 2006 by Dr. Yaron River, chief physician at the Neurology Department, Hillel Yaffe Medical Center, Hadera. The company has raised $1.5 million from private investors, the Misgav Venture Accelerator, and government R&D grants.

Media relations:
Efrat Kaduri
Ofir Shpigel Media and Public Relations

SOURCE Headway Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Fujifilm Spotlights DR Expansion, Innovation At RSNA 2012
2. Jury for 2012 Intercultural Innovation Award Announced
3. Le Dr Beau Lotto se joint aux grands penseurs à loccasion du débat sur linnovation 2012
4. Le professeur Brian Cox se joint aux grands penseurs à loccasion du débat sur linnovation 2012
5. Cutting-Edge German Medical Innovations Put Patients First
6. El profesor Brian Cox se une a los grandes pensadores en The Innovation Debate 2012
7. El doctor Beau Lotto se une a los grandes pensadores en The Innovation Debate 2012
8. MabVax Therapeutics Closes $5.25 Million Financing with Numoda Capital Innovations, Burrill Capital Fund IV, and RTP Venture Fund
9. CardioMEMS Named as a Finalist for Intel Innovation Award
10. Innovations in Ophthalmic Devices - Anterior Segment
11. Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund
Post Your Comments:
(Date:10/5/2017)... ROSEMONT, Ill. , Oct. 5, 2017 /PRNewswire-USNewswire/ ... American Association of Oral and Maxillofacial Surgeons (AAOMS) ... than opioids – to be used as a ... post-surgical pain. ... relationship, the AAOMS White Paper "Opioid Prescribing: Acute ...
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
(Date:10/12/2017)... ... October 12, 2017 , ... Dr. Parsa Mohebi, the Los ... article to the newly revamped Cosmetic Town journal section, featuring articles ... procedure known as Follicular Unit Extraction (FUE). , Dr. Mohebi says ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, ... relay – Miles by Moonlight to raise money for the American Heart Association Heart ... , Teams will work together to keep their treadmills moving for 5 hours. ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in property taxes a year. In some states—like New York, New Jersey, Massachusetts, ... contrast, many overseas retirement havens have extremely low property-tax rates, which contributes to ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... enhanced Pepper Flow promotional review platform at the Promotional Review Committee Compliance ... capabilities help marketers streamline the medical, legal, and regulatory review (MLR) process ...
Breaking Medicine News(10 mins):